Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Alexandra Stowell et al.|Nature Cancer|2021Cited by 279
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Giovanna Bergamini, Thilo Werner et al.|Nature Biotechnology|2020Cited by 195